Clinical guideline for MDMA addresses uncertainty and misinformation, patients call for more accessible pharmacies, new role for Fei Sim, and more
Click here to download Pharmacy Daily for Friday 13th February 2026
PARTNER SITES
Other recent headlines
-
World-first clinical guide for MDMA
Friday | Feb 13 2026A NEW Australian Clinical Practice Guideline for the Appropriate Use of methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD) has been approved by the National Health and Medical Research Council (NHMRC).
-
Is your pharmacy truly accessible?
Friday | Feb 13 2026CUSTOMERS are calling out for retail pharmacies to improve their store design and become more accessible, writes senior editor and advocacy manager Rosemary Ainley from patient-support group GHLF Australia.
-
College celebrates 50 years
Thursday | Feb 12 2026THE Australasian College of Pharmacy marked 50 years of leadership, education and professional excellence with a celebration dinner held in Brisbane on Tue night.
to top